Press Release: Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid
Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal...
Cancer
Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging Featured at SNMMI 2025
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”)...
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT)...
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT)...
RyboDyn Selected to Join Lilly Gateway Labs to Advance Next-Gen Immunotherapies Targeting the Dark Proteome
Lilly Collaboration Accelerates RyboDyn's Dark Proteome Targets Toward First-in-Class Therapies SAN DIEGO, June 19, 2025 /PRNewswire/ -- RyboDyn, Inc., a...
Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress
PRESS RELEASE Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in...
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests...
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapiesDURHAM, N.C. and WEST VALLEY CITY, Utah, June...
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
In-vitro lab results confirmed that the Company’s cell targeting nanoparticles successfully entered cancer cells and avoided non-cancerous cellsLehi, June 19,...
SandboxAQ Unveils SAIR, (Structurally Augmented IC50 Repository), a Novel Open Dataset of Protein-Ligand Structures Labelled By Binding Affinities
PALO ALTO, Calif., June 18, 2025 /PRNewswire/ -- SandboxAQ today announced the launch of SAIR (Structurally Augmented IC50 Repository), the...
Oklahoma Cancer Specialists and Research Institute Selects BioCareSD and AllyGPO as Primary Drug Distributor and GPO Partner
TULSA, Okla., June 18, 2025 /PRNewswire/ -- Oklahoma Cancer Specialists and Research Institute (OCSRI), a leading independent community oncology practice, has...
START Launches Hope Hub to Connect Patients, Physicians, and Advocacy Groups to Community-Based Cancer Trials
The new platform is designed to break down barriers to early-phase trial access, bringing "Hope Through Access" to communities and...
Blue Earth Diagnostics Reinforces Leadership in Prostate Cancer Imaging and Highlights Expanding Pipeline at Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025
BOSTON, June 18, 2025 /PRNewswire/ -- Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of...
New Study Reveals Americans Lost 120 Total Nights of Sleep Over a Five-Year Period, Negatively Impacting Cardiovascular Health, Weight and Longevity
Data from connected health wearables company, Withings, shows how poor sleep impacts cardiovascular risk and longevity across the US –...
Remepy’s Mobile App Shown to Rewire Brain, Modulate Immune System and Improve Mood in Adults with Subjective Cognitive Decline
RMPY-008 is the first app-based intervention to demonstrate rapid modulation of inflammatory blood biomarkers, acting like a digital antibody in...
Intelliseq Integrates Genomenon’s Cancer Knowledgebase (CKB) into iFlow Platform to Advance Somatic Variant Interpretation
ANN ARBOR, Mich. and SAN DIEGO and KRAKÓW, Poland, June 18, 2025 /PRNewswire/ -- Intelliseq, a leader in computational genomics...
PreciseDx Continues Path to Commercial Launch: Secures Additional Funding and Announces New Leadership
Funding now totals over $43 million, strengthened leadership focused on a 2026 commercial launch of the OncoIntelligence™-driven, PreciseBreast™ NEW YORK, June...
Willis Knighton Health Live with 132 Clinics on MEDITECH Expanse
Clinics and hospitals unified on one EHR platform for a single patient record across all facilitiesCANTON, Mass.--(BUSINESS WIRE)--#EHR--Willis Knighton Health...
Akari Therapeutics Bolsters Global IP Estate for its Novel Antibody Drug Conjugate (ADC) Immuno-Oncology Payload, PH1, with Recent Granting of Patent Protection Across India
Differentiated PH1 payload is a spliceosome inhibitor designed to inhibit RNA splicing, leading to cancer cell death and activation of...
Prenetics Becomes First Healthcare Company to Execute Aggressive Bitcoin Treasury Strategy, Secures $20M in BTC, Appoints Former OKEx COO to Board
- Prenetics adopts proven corporate Bitcoin strategy inspired by MicroStrategy's ~$40B Bitcoin holdings and Metaplanet's meteoric treasury transformation - Following...